Zydus gets US okay for skin ointment
Drug firm Zydus Cadila on Monday said it has received approval from the US health regulator to market Clobetasol Propionate ointment, used to treat a range of skin conditions, in the American market. The company has received final approval from the US Food and Drug Administration to market its product, Zydus Cadila said in a statement. The ointment will be manufactured at the company’s Ahmedabadbased facility. The Zydus group has now more than 165 product approvals.